|
| Screening Matters Issue 7, March-April 2012
Welcome
Welcome to the March/April newsletter to update on the work of the UK NSC. These newsletters have now been going for over a year and I really hope you find them useful. We have created a short 1 minute survey to gather feedback and we would be extremely grateful if you'd fill it in once you've read this edition. » Access the survey here (it will open in a separate window)There has been significant progress in Quality Assurance (QA) – the programme to assess the most effective model of screening QA has come to an end and the evaluation report is in draft and will be published by summer. I am delighted to be able to tell you that we have made the following appointments for the new QA leads: Madeleine Johnson - North, Jane Woodland - Midlands and East, Morag Armer - South. These are one year secondments and will start as soon as possible. In addition the team will be joined by Alison Frater who will be leading on some cross cutting initiatives for the UK NSC and will lead on QA for London The new QA leads will work with our regional and national QA teams to develop our approach to QA as we move into new structures. We have the go ahead to procure an IT system to provide a failsafe between newborn laboratories and the maternity services. Currently the baby has a heel prick at 5-8 days and the card is posted to the lab. Identifying children who have missed the test relied on checks of population coverage via child health record departments. This should happen roughly around day 17. However, the UK Newborn Screening Programme Centre (responsible for the blood spot programme) recommend that babies with these conditions be enrolled in care by 21 days. This timescale allows very little time to find 'missing babies'. And in some cases the mother and baby have moved address. The aim of the new IT system is to let the maternity services know which babies have been tested and blood spot cards have arrived in the lab and which are missing or need another sample. When piloted we found it identified several babies who had not been tested but the lab, CHD and maternity services were not aware. We aim to procure the IT system by summer and roll out through to the end of this financial year. As always we are busy and anyone wanting to get involved, contact me via the website email form. Dr Anne Mackie, Director of Programmes, UK National Screening Committee
News in BriefMap of MedicineThe Map of Medicine now requires registration to view the care maps on NHS Evidence. Registration is free, extremely quick and you'll only need to do it once, so don't let it put you off. PDF versions of the care maps can still be downloaded without registration from the individual screening programme websites.
Policy NewsThe UK NSC has over a hundred screening policies on conditions ranging from anaemia in pregnancy to vision in adults. These are reviewed on a three-year cycle. Full information on the policy review process is available. Current policy consultationsThese are the policies currently being consulted on:
New consultations due to start soon
Training and Education |
| Syphilis | 21 May |
| Hepatitis B | 28 May |
| HIV | 22 May |
The lab workshops were held in March with over 130 delegates attending over 4 days. The evaluations were very positive and some comments from the events have included "I now understand what difference my role makes to women and babies" and "Have been doing this for a long time (screening for IDPS) but you can still learn something new".
The events were so successful that we are considering holding an annual event for lab leads. Further evaluation and examples of good practise from the events will shortly be available on the website.

The review of information to support parents and health professionals once a diagnosis of a congenital anomaly has been made and is now complete. This information includes leaflets covering the following conditions: Anencephaly, bilateral renal agenesis, serious congenital cardiac anomalies, congenital diaphragmatic hernia, cleft lip, exomphalos, gastroschisis, Trisomy 18, Trisomy 13, lethal skeletal dysplasia and spina bifida. Two copies of a book containing these leaflets are being sent to all ultrasound departments in England and they are also available online.
In accordance with the on-going work within NHS FASP to develop clinical care pathways for the 11 conditions identified in the base menu of the 18+0 to 20+6 weeks fetal anomaly scan standards, work has begun on the cardiac pathway. A stakeholder event was held on 1 March 2012 in London with a wide range of stakeholders present, including clinicians, charities, support groups, parents and lay representation. The event was extremely well received and the draft pathway will be released for national consultation in the coming months.
As part of the task to develop care pathways for the 11 conditions NHS FASP has launched a consultation to discuss key elements of an integrated care pathway for cleft lip. The consultation will be open from 16 April to 11 May 2012.
NHS Linked Antenatal and Newborn Sickle Cell and Thalassaemia (SCT) Screening ProgrammeDayglo, the theatre project produced by Y touring with its strong sub plot about sickle cell has won the STEM Category of the National Science & Engineering Week Event Awards 2012. The Sickle Cell and Thalassaemia Screening Programme was one of the sponsors of the project and was closely involved in the development of key resources about sickle cell for it.
» Find out about the play, the vision for the project, the resources for schools and about Y Touring
The programme has launched an information leaflet for all healthcare professionals describing the linked antenatal and newborn screening programme for sickle cell and thalassaemia. Health care professionals are able to see where their role fits with the screening programme and patient pathway. The leaflet can be ordered from Harlow Press by calling 0191 496 9735 or emailing national.screening@harlowprinting.co.uk
March saw the launch of the National Haemoglobinopathy Project commissioning guide – a series of documents to aid commissioners in providing quality care right from when a baby is diagnosed with a haemoglobin disorder. The aim is to ensure a seamless transition from screening to care and the guide provides a sound foundation for quality care which is essential for an effective and ethical screening programme.
Together with the Newborn Bloodspot Programme, the SCT Programme has developed a protocol aimed at clarifying reporting arrangements for newborn screening results: normal results.
At the RCN Congress in May, the SCT Programme will launch its report on the benefits of specialist nurses for sickle cell and for thalassaemia. Supported by the Roald Dahl Marvellous Children's Charity, the report is the culmination of a six month project exploring the benefits of specialist nurses in this field and the cost effectiveness of continuing or expanding the number of such posts. A link to the report will be included in the next Screening Matters.
NHS Newborn Blood Spot Screening ProgrammeThis special edition of FootPrint celebrates the Programme Centre's 10th anniversary. You can also read messages from screening colleagues and download a timeline of newborn screening milestones from our special anniversary section on our website.
» Download the FootPrint newsletter or find out more about the 10th anniversary
Annual data collection for Child Health Records Departments and Newborn Screening Laboratories for 2011-12 has closing dates for submission of the 30th June and 31st July 2012 respectively. Please ensure that a nominated individual is made responsible for data submission in each organisation and that you are informed of any problems which may prevent timely submission of your data so these can be resolved.
» Download the data collection templates and information
The revised policy for CHT screening in preterm infants was implemented in all four UK countries on 1 April 2012. The revised policy is based on gestational age criteria of less than 32 weeks (less than or equal to 31+6 days) and repeat testing at 28 days postnatal age, counting date of birth as day 0, or discharge home, whichever is the sooner.
A range of education and training resources and a transition plan to support decommissioning the old policy and implementing the new are available electronically and in hard copy.
NHS Newborn Hearing Screening Programme (NHSP)As part of National Knowledge Week for Hearing, NHSP held their annual conference entitled "Adding Value: Improving Quality at Every Step of the Care pathway" on 28 March 2012. Over 200 delegates representing professionals from across the care pathway attended the conference and actively contributed through engagement in seminars, questions to the speaker panel, and enthusiastic networking. NHSP is grateful to all speakers, seminar leaders, staff and delegates for making 2012 the most successful conference thus far.
The presentations will shortly be available on the NHSP website.
NHS Newborn and Infant Physical Examination (NIPE) Screening ProgrammeIn order to ensure consistency and provide a clear way forward, the NIPE Programme has decided to postpone the consultation on the revised NIPE Standards. The UK National Screening Committee (UKNSC) will be considering the value of the introduction of pulse oximetry for congenital heart defects as an addition to the clinical examination. In these circumstances, it was decided that a national consultation on the revised care pathways for congenital heart disease before a decision had been reached by the UKNSC would be unwise. As the four screening components form one group, carried out at the same time, the consultation on all components should take place concurrently. Therefore, it has been decided to delay the national consultation on all pathways and standards until the decision on pulse oximetry has been made by the UK NSC, and when the NIPE congenital heart defects' pathway and standards can reflect that decision.
NHS Diabetic Eye Screening Programme (DESP)All local diabetic eye screening programmes will move over to a new common screening pathway ahead of the screening programme's transition to Public Health England in April 2013. A new national service specification for diabetic eye screening is being developed to reflect these pathway changes and local programmes will in future be commissioned against this specification.
In March, the NHS Diabetic Eye Screening Programme held four workshops for local clinical leads and programme managers across England to cover some of the key issues around the implementation of the new pathway and grading criteria. The workshops were very well attended and well received. Presentations from the workshops, along with a comprehensive pathway implementation manual and a list of nearly 100 questions and answers from the events have now been made available to programmes via the NHS DESP extranet. In addition, there are a total of 13 short online video clips in which National Programme Director Prof Peter Scanlon and National QA Director Dr Sue Cohen address the key issues.
» View the pathway and grading criteria information, including videos, on the DESP website (login required)
Richard Lane OBE, President of Diabetes UK, gave a ringing endorsement to diabetic eye screening when he visited the NHS DESP stand at the annual Diabetes UK Professional Conference in Glasgow in March. Mr Lane, who has himself undergone successful eye laser treatment for screen-detected diabetic eye disease, will be featured in the Spring 2012 edition of the NHS DESP newsletter.
NHS DESP is now liaising with Diabetes UK to raise awareness of the charity's 15 Healthcare Essentials campaign. The campaign seeks to inform people with diabetes of all the health checks and services that they should receive. The national programme is looking into the practicalities of patients accessing 15 Healthcare Essentials leaflets at screening clinics.
The new NHS DESP invitation leaflet has now been printed and is available for local programmes to order. The leaflet is being printed and distributed to local programmes by Harlow Printing. This company also prints and distributes patient information materials for antenatal and newborn screening programmes. NHS DESP invitation letter templates have also been revised to coincide with the new leaflet.
NHS Abdominal Aortic Aneurysm (AAA) Screening ProgrammePhase 3 – the largest phase of the NHS AAA Screening Programme's national implementation – is complete. The AAA programme now covers approximately 75% of England. The remainder of the country will roll out screening during Phase 4, the final national implementation phase, between October 2012 and March 2013.
Provisional data extracted from the NHS AAA Screening Programme's national IT system shows that just over four out of every five men invited for screening took up the offer during the national programme's first three years of operation (April 2009 to March 2012). During that time, well over 150,000 men were screened, just under 2,500 aneurysms were detected for the first time and 141 men were referred to vascular surgeons to discuss treatment options.
The first ever UK-wide audit of elective AAA repair surgery revealed a dramatic improvement in outcomes for patients in recent years. The National Vascular Database audit of elective AAA repairs revealed an overall mortality rate for elective infra renal AAA procedures of just 2.4%. The NHS AAA Screening Programme has worked closely with the Vascular Society of Great Britain and Ireland on the development of vascular networks and quality improvement processes that have helped to drive this improvement in patient outcomes.
The NHS AAA Screening Programme hosted an international AAA screening research meeting at the Charing Cross International Symposium on 15 April when there were presentations on AAA screening from colleagues in Sweden, Denmark, Australia, Finland, New Zealand, Italy and Norway.
![]()
Suggest stories for future issues or tell us what you think of this bulletin and how we can make it more useful by contacting Nick Waddell.
If you or a colleague would like to be notified by email when Screening Matters in published, please also contact Nick Waddell.
![]()